Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens

Satoshi Yamasaki, Akiko Miyagi-Maeshima, Yasuo Kakugawa, Yoshihiro Matsuno, Fusako Ohara-Waki, Shigeo Fuji, Yuriko Morita-Hoshi, Masakazu Mori, Sung Won Kim, Shin Ichiro Mori, Takahiro Fukuda, Ryuji Tanosaki, Tadakazu Shimoda, Kensei Tobinai, Daizo Saito, Yoichi Takaue, Takanori Teshima, Yuji Heike

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Colonoscopic evaluation of mucosal tissues after allogeneic hematopoietic stem cell transplantation (HSCT) is very useful in evaluating pathogenesis and diagnosis of intestinal graft-versus-host disease (GVHD). However, information on the timing and sites of biopsies and the immunohistological evaluation of mucosal tissues for diagnosing intestinal GVHD, especially following reduced-intensity (RIC) regimens, remains very limited. A total of 33 patients with histologically proven GVHD after allogeneic HSCT with RIC (n = 23) and myeloablative conditioning (MAC, n = 10) regimens were enrolled in the present study. Colonoscopy was performed due to gastrointestinal symptoms, especially diarrhea and anorexia. Sites of biopsies with the worst histopathological grading were the terminal ileum in 67 % of patients. In the RIC group, the onset of diarrhea prior to colonoscopy examination was later (median: RIC, 57 vs. MAC, 27 days) and the number of patients who developed abdominal pain tended to be higher (RIC, 70 % vs. MAC, 30 %). A lower number of CD4+ cells and a higher ratio of Foxp3+ cells to CD4+ cells were detected in the involved lesions of intestinal GVHD following RIC. These differences in the RIC and MAC groups suggest that regimen-specific therapeutic strategies are required for diagnosing intestinal GVHD.

Original languageEnglish
Pages (from-to)421-426
Number of pages6
JournalInternational Journal of Hematology
Volume97
Issue number3
DOIs
Publication statusPublished - 2013 Mar
Externally publishedYes

Fingerprint

Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
Colonoscopy
Diarrhea
Mucous Membrane
Biopsy
Anorexia
Ileum
Abdominal Pain
Cell Count

Keywords

  • Allogeneic hematopoietic stem cell transplantation
  • Colonoscopy
  • HLA-matched donor
  • Intestinal graft-versus-host disease
  • Reduced-intensity regimen

ASJC Scopus subject areas

  • Hematology

Cite this

Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens. / Yamasaki, Satoshi; Miyagi-Maeshima, Akiko; Kakugawa, Yasuo; Matsuno, Yoshihiro; Ohara-Waki, Fusako; Fuji, Shigeo; Morita-Hoshi, Yuriko; Mori, Masakazu; Kim, Sung Won; Mori, Shin Ichiro; Fukuda, Takahiro; Tanosaki, Ryuji; Shimoda, Tadakazu; Tobinai, Kensei; Saito, Daizo; Takaue, Yoichi; Teshima, Takanori; Heike, Yuji.

In: International Journal of Hematology, Vol. 97, No. 3, 03.2013, p. 421-426.

Research output: Contribution to journalArticle

Yamasaki, S, Miyagi-Maeshima, A, Kakugawa, Y, Matsuno, Y, Ohara-Waki, F, Fuji, S, Morita-Hoshi, Y, Mori, M, Kim, SW, Mori, SI, Fukuda, T, Tanosaki, R, Shimoda, T, Tobinai, K, Saito, D, Takaue, Y, Teshima, T & Heike, Y 2013, 'Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens', International Journal of Hematology, vol. 97, no. 3, pp. 421-426. https://doi.org/10.1007/s12185-013-1297-9
Yamasaki, Satoshi ; Miyagi-Maeshima, Akiko ; Kakugawa, Yasuo ; Matsuno, Yoshihiro ; Ohara-Waki, Fusako ; Fuji, Shigeo ; Morita-Hoshi, Yuriko ; Mori, Masakazu ; Kim, Sung Won ; Mori, Shin Ichiro ; Fukuda, Takahiro ; Tanosaki, Ryuji ; Shimoda, Tadakazu ; Tobinai, Kensei ; Saito, Daizo ; Takaue, Yoichi ; Teshima, Takanori ; Heike, Yuji. / Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens. In: International Journal of Hematology. 2013 ; Vol. 97, No. 3. pp. 421-426.
@article{080aaf466f384734af6c2f4a6f07b7d4,
title = "Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens",
abstract = "Colonoscopic evaluation of mucosal tissues after allogeneic hematopoietic stem cell transplantation (HSCT) is very useful in evaluating pathogenesis and diagnosis of intestinal graft-versus-host disease (GVHD). However, information on the timing and sites of biopsies and the immunohistological evaluation of mucosal tissues for diagnosing intestinal GVHD, especially following reduced-intensity (RIC) regimens, remains very limited. A total of 33 patients with histologically proven GVHD after allogeneic HSCT with RIC (n = 23) and myeloablative conditioning (MAC, n = 10) regimens were enrolled in the present study. Colonoscopy was performed due to gastrointestinal symptoms, especially diarrhea and anorexia. Sites of biopsies with the worst histopathological grading were the terminal ileum in 67 {\%} of patients. In the RIC group, the onset of diarrhea prior to colonoscopy examination was later (median: RIC, 57 vs. MAC, 27 days) and the number of patients who developed abdominal pain tended to be higher (RIC, 70 {\%} vs. MAC, 30 {\%}). A lower number of CD4+ cells and a higher ratio of Foxp3+ cells to CD4+ cells were detected in the involved lesions of intestinal GVHD following RIC. These differences in the RIC and MAC groups suggest that regimen-specific therapeutic strategies are required for diagnosing intestinal GVHD.",
keywords = "Allogeneic hematopoietic stem cell transplantation, Colonoscopy, HLA-matched donor, Intestinal graft-versus-host disease, Reduced-intensity regimen",
author = "Satoshi Yamasaki and Akiko Miyagi-Maeshima and Yasuo Kakugawa and Yoshihiro Matsuno and Fusako Ohara-Waki and Shigeo Fuji and Yuriko Morita-Hoshi and Masakazu Mori and Kim, {Sung Won} and Mori, {Shin Ichiro} and Takahiro Fukuda and Ryuji Tanosaki and Tadakazu Shimoda and Kensei Tobinai and Daizo Saito and Yoichi Takaue and Takanori Teshima and Yuji Heike",
year = "2013",
month = "3",
doi = "10.1007/s12185-013-1297-9",
language = "English",
volume = "97",
pages = "421--426",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens

AU - Yamasaki, Satoshi

AU - Miyagi-Maeshima, Akiko

AU - Kakugawa, Yasuo

AU - Matsuno, Yoshihiro

AU - Ohara-Waki, Fusako

AU - Fuji, Shigeo

AU - Morita-Hoshi, Yuriko

AU - Mori, Masakazu

AU - Kim, Sung Won

AU - Mori, Shin Ichiro

AU - Fukuda, Takahiro

AU - Tanosaki, Ryuji

AU - Shimoda, Tadakazu

AU - Tobinai, Kensei

AU - Saito, Daizo

AU - Takaue, Yoichi

AU - Teshima, Takanori

AU - Heike, Yuji

PY - 2013/3

Y1 - 2013/3

N2 - Colonoscopic evaluation of mucosal tissues after allogeneic hematopoietic stem cell transplantation (HSCT) is very useful in evaluating pathogenesis and diagnosis of intestinal graft-versus-host disease (GVHD). However, information on the timing and sites of biopsies and the immunohistological evaluation of mucosal tissues for diagnosing intestinal GVHD, especially following reduced-intensity (RIC) regimens, remains very limited. A total of 33 patients with histologically proven GVHD after allogeneic HSCT with RIC (n = 23) and myeloablative conditioning (MAC, n = 10) regimens were enrolled in the present study. Colonoscopy was performed due to gastrointestinal symptoms, especially diarrhea and anorexia. Sites of biopsies with the worst histopathological grading were the terminal ileum in 67 % of patients. In the RIC group, the onset of diarrhea prior to colonoscopy examination was later (median: RIC, 57 vs. MAC, 27 days) and the number of patients who developed abdominal pain tended to be higher (RIC, 70 % vs. MAC, 30 %). A lower number of CD4+ cells and a higher ratio of Foxp3+ cells to CD4+ cells were detected in the involved lesions of intestinal GVHD following RIC. These differences in the RIC and MAC groups suggest that regimen-specific therapeutic strategies are required for diagnosing intestinal GVHD.

AB - Colonoscopic evaluation of mucosal tissues after allogeneic hematopoietic stem cell transplantation (HSCT) is very useful in evaluating pathogenesis and diagnosis of intestinal graft-versus-host disease (GVHD). However, information on the timing and sites of biopsies and the immunohistological evaluation of mucosal tissues for diagnosing intestinal GVHD, especially following reduced-intensity (RIC) regimens, remains very limited. A total of 33 patients with histologically proven GVHD after allogeneic HSCT with RIC (n = 23) and myeloablative conditioning (MAC, n = 10) regimens were enrolled in the present study. Colonoscopy was performed due to gastrointestinal symptoms, especially diarrhea and anorexia. Sites of biopsies with the worst histopathological grading were the terminal ileum in 67 % of patients. In the RIC group, the onset of diarrhea prior to colonoscopy examination was later (median: RIC, 57 vs. MAC, 27 days) and the number of patients who developed abdominal pain tended to be higher (RIC, 70 % vs. MAC, 30 %). A lower number of CD4+ cells and a higher ratio of Foxp3+ cells to CD4+ cells were detected in the involved lesions of intestinal GVHD following RIC. These differences in the RIC and MAC groups suggest that regimen-specific therapeutic strategies are required for diagnosing intestinal GVHD.

KW - Allogeneic hematopoietic stem cell transplantation

KW - Colonoscopy

KW - HLA-matched donor

KW - Intestinal graft-versus-host disease

KW - Reduced-intensity regimen

UR - http://www.scopus.com/inward/record.url?scp=84887573718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887573718&partnerID=8YFLogxK

U2 - 10.1007/s12185-013-1297-9

DO - 10.1007/s12185-013-1297-9

M3 - Article

C2 - 23435651

AN - SCOPUS:84887573718

VL - 97

SP - 421

EP - 426

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 3

ER -